Stem Cell Company REPROCELL (Japan) Acquires 3D Cell Culture Company Reinnervate (UK) and Human Tissue Supplier BioServe (USA)
05 August 2014
Location: REPROCELL Inc. (Yokohama, Japan) Date: August 5, 2014 The Japanese regenerative medicine company REPROCELL Inc. has announced the acquisition of Reinnervate Ltd. (UK), one of the leading companies in the field of 3D cell culture. ...
Scottish company creates first searchable database of human pharmacological responses in functional intact tissues
25 February 2014
Biopta Ltd, the human tissue-based contract research organisation, today announced a major development in discovery research with the launch of the first catalog of assays based on human functional tissues. The catalogue serves to provide t...
Launch of Reinnervate Perfusion System for 3D cell culture
05 February 2014
Reinnervate today announced the launch of a low-cost, simple system for combining 3D cell culture with dynamic circulation and perfusion of media. This product allows scientists to create cell based models that are another step closer to th...
Biopta collaborates with Merck to investigate in vivo cardiac effects
13 November 2013
In a recent collaboration with Merck, Biopta conducted human functional tissue experiments to investigate the mechanisms underlying two anti-arrhythmic drugs. Hemodynamic effects are often noted as adverse events with the use of antiarrhyth...
Reinnervate Ltd partners with Oncotest and SBH Sciences on introductory services for screening novel anti-cancer drugs using 3D tumour cell culture
04 November 2013
Sedgefield, UK. November 2013 – 3D cell culture company Reinnervate Ltd today announced partnerships with two oncology-focussed CRO’s to offer 3D tumour cell screening services. The CROs, Oncotest GmbH (Freiburg, Germany) and SBH Sciences (...
Reinnervate Ltd and Roslin Cellab to partner around 3D stem cell printing products and technologies
19 September 2013
Sedgefield, UK. September 2013 – Specialist 3D cell culture company Reinnervate Ltd today announced that it is entering into a collaboration with leading stem cell company Roslin Cellab to develop 3D stem cell printing products and services...
Prof. Stefan Przyborski to participate at the XCellR8 Human Primary Cell Culture course, 7 November 2013
22 August 2013
Reinnervate’s CSO, Professor Stefan Przyborski, will be participating at the XCellR8 Human Primary Cell Culture course, which will be held on 7-8 November 2013 at their new premises in the Sci-Tech Daresbury Innovation Centre, UK. As part o...
Alvetex 3D cell culture scaffolds chosen by investigators at Massachusetts General Hospital for study of bone loss during space flight
31 July 2013
Planning 3D Osteocyte cell culture experiments on 2014 International Space Station (ISS) mission Sedgefield, UK. August 2013 – Market leading 3D cell culture company Reinnervate Ltd today announced that its Alvetex® Scaffold system has been...
Scottish SMEs Announce Collaboration with Universities, Industry and NHS in Establishment of a £20m Stratified Medicine Scotland Innovation Centre
23 April 2013
Today Scotland’s First Minister Alex Salmond announced the creation of a £20M Stratified Medicine Scotland Innovation Centre (SMS-IC), at the new South Glasgow Hospitals Campus. This is one of three innovation centres to be funded and signa...
3D cell culture firm Reinnervate and specialist Oncology CRO Oncotest GmbH enter collaboration agreement
07 January 2013
Oncotest to offer enhanced pre-clinical oncology and cancer research screening services incorporating Alvetex® Scaffold 3D cell culture technology Sedgefield, UK. 07th January 2013 – Market leading 3D cell culture company, Reinnervate Ltd, ...